[go: up one dir, main page]

BR9809571A - Composição medicinal e processo para produzì-la - Google Patents

Composição medicinal e processo para produzì-la

Info

Publication number
BR9809571A
BR9809571A BR9809571-4A BR9809571A BR9809571A BR 9809571 A BR9809571 A BR 9809571A BR 9809571 A BR9809571 A BR 9809571A BR 9809571 A BR9809571 A BR 9809571A
Authority
BR
Brazil
Prior art keywords
medicinal composition
produce
surfactants
drug
insoluble
Prior art date
Application number
BR9809571-4A
Other languages
English (en)
Inventor
Fumio Shimojo
Sumihisa Kimura
Takeo Hirose
Satoshi Ueda
Rinta Ibuki
Norio Ohnishi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of BR9809571A publication Critical patent/BR9809571A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçãO MEDICINAL E PROCESSO PARA PRODUZì-LA". é provida uma composição medicinal tendo um perfil de liberação de droga bastante satisfatório e um perfil de absorção de droga bastante satisfatório após administração oral, caracterizada por compreender uma droga insolúvel e dois ou mais surfactantes, pelo menos um dos surfactantes tendo dissolvido no mesmo a droga insolúvel e o outro surfactante ou surfactantes.
BR9809571-4A 1997-04-11 1998-04-07 Composição medicinal e processo para produzì-la BR9809571A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9371597 1997-04-11
PCT/JP1998/001585 WO1998046268A1 (fr) 1997-04-11 1998-04-07 Composition medicamenteuse

Publications (1)

Publication Number Publication Date
BR9809571A true BR9809571A (pt) 2000-07-04

Family

ID=14090123

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809571-4A BR9809571A (pt) 1997-04-11 1998-04-07 Composição medicinal e processo para produzì-la

Country Status (8)

Country Link
US (1) US6316473B1 (pt)
EP (1) EP0978288A4 (pt)
JP (1) JP4221762B2 (pt)
KR (1) KR20010006070A (pt)
CN (1) CN1259053A (pt)
BR (1) BR9809571A (pt)
CA (1) CA2284988A1 (pt)
WO (1) WO1998046268A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT851753E (pt) 1995-09-19 2004-04-30 Fujisawa Pharmaceutical Co Composicoes em aerossol
KR100406823B1 (ko) * 1998-04-27 2003-11-21 후지사와 야꾸힝 고교 가부시키가이샤 의약 조성물
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US6790228B2 (en) 1999-12-23 2004-09-14 Advanced Cardiovascular Systems, Inc. Coating for implantable devices and a method of forming the same
US7807211B2 (en) 1999-09-03 2010-10-05 Advanced Cardiovascular Systems, Inc. Thermal treatment of an implantable medical device
AUPR529701A0 (en) * 2001-05-28 2001-06-21 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition
TWI324925B (en) * 2001-08-23 2010-05-21 Novartis Ag Ophthalmic composition
WO2004069180A2 (en) * 2003-01-31 2004-08-19 Smithkline Beecham Corporation Solid dispersion compositions
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
MXPA06000370A (es) * 2003-07-09 2006-03-28 Chong Kun Dang Pharm Corp Dispersion solida de tacrolimus.
CA2547597A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
KR100866728B1 (ko) * 2004-11-12 2008-11-03 주식회사종근당 타크로리무스를 함유하는 주사제
US8222272B2 (en) 2008-04-11 2012-07-17 Roxane Laboratories, Inc. Pharmaceutical formulation and process comprising a solid dispersion of macrolide (tacrolimus)
IT1393742B1 (it) 2009-04-23 2012-05-08 Repossi Macchine Agricole S R L Ranghinatore spandivoltafieno a pettini multlipo e multifunzionale
CN101869547B (zh) 2009-04-24 2012-02-22 张娜 一种他克莫司注射制剂
BR112012023044A2 (pt) 2010-03-12 2016-08-30 Monsanto Technology Llc composições para saúde de planta compreendendo um pesticida solúvel em água e um agroquímico insolúvel em água.
JP5567909B2 (ja) * 2010-06-17 2014-08-06 東洋カプセル株式会社 タクロリムス含有カプセル剤
PH12013502368A1 (en) * 2011-05-20 2014-01-06 Aventisub Llc Pharmaceutical composition comprising fexofenadine
JP7697681B2 (ja) * 2021-06-15 2025-06-24 ユニケム株式会社 含フッ素ポリマーおよび界面活性剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430455D0 (en) * 1984-12-03 1985-01-09 Fujisawa Pharmaceutical Co Fr-900506 substance
GB8608080D0 (en) 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
KR0159766B1 (ko) * 1989-10-16 1998-12-01 후지사와 토모키치로 양모제 조성물
GB8925797D0 (en) * 1989-11-15 1990-01-04 Fisons Plc Compositions
JPH04103525A (ja) * 1990-08-22 1992-04-06 Sanwa Kagaku Kenkyusho Co Ltd 難水溶性薬物の持続性製剤化方法
IE65341B1 (en) 1990-11-08 1995-10-18 Fujisawa Pharmaceutical Co Suspensions containing tricyclic compounds
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
DE4329503A1 (de) * 1993-09-01 1995-03-02 Galenik Labor Freiburg Gmbh Pharmazeutische Präparate zur gezielten Behandlung von Morbus Crohn und Colitis Ulcerosa
GB2315216B (en) * 1993-10-05 1998-10-14 Ciba Geigy Ag Microemulsion preconcentrates comprising FK506 or 33-epi-chloro-33-desoxy-ascomycin
MY129435A (en) * 1994-10-26 2007-04-30 Novartis Ag Pharmaceutical microemulsion preconcentrates

Also Published As

Publication number Publication date
EP0978288A1 (en) 2000-02-09
EP0978288A4 (en) 2006-07-12
CA2284988A1 (en) 1998-10-22
CN1259053A (zh) 2000-07-05
KR20010006070A (ko) 2001-01-15
JP4221762B2 (ja) 2009-02-12
WO1998046268A1 (fr) 1998-10-22
US6316473B1 (en) 2001-11-13

Similar Documents

Publication Publication Date Title
BR9809571A (pt) Composição medicinal e processo para produzì-la
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
BR9811121A (pt) Produto, composição farmacêutica, e uso de um produto
DE3583799D1 (de) Feste zubereitung mit langsamer freisetzung.
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
DK0959888T3 (da) Anvendelse af det chelerende middel clioquinol til fremstillingen af et farmaceutisk præparat til behandlingen af Alzheimer's sygdom
KR920019342A (ko) 골질환 치료제
BR0107869A (pt) Composições farmacêuticas eletrogiradas
DE60143393D1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
EA200200106A1 (ru) Фармацевтическая композиция леводопа/карбидопа/энтакапон
BR0009770A (pt) Derivados de bisindóis indigóides capazes de penetrarem na membrana de células, formulação farmacêutica e utilização da mesma
BR9303469A (pt) Conjugado de interferon,composto,processo de preparacao de um conjugado de interferon,use e composicoes farmaceuticas
EA200100541A1 (ru) Фармацевтическая композиция с модифицированным высвобождением сенсибилизатора к инсулину и других антидиабетических агентов
BR9404330A (pt) Dispositivo para misturar uma composição farmacêutica com um outro agente, processo para preparar um preparado farmacêutico mediante a mistura de uma composição farmacêutica com um agente, e, processo para a aplicação oral de um preparado farmacêutico.
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
IT1246188B (it) Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
KR920702216A (ko) 아세틸 d-카르니틴의 녹내장 치료에의 용도
BR9811478A (pt) Composições de polìmero-ácido tânico para a liberação controlada de agentes farmacêuticos particularmente na cavidade oral
BR0007294A (pt) Formulações farmacêuticas aperfeiçoadas
EE04493B1 (et) Tsüklopenteeni derivaadid, neid sisaldav farmatseutiline kompositsioon ning ühendite kasutamine ravimina inimestel esinevate motiliini retseptoriga seotud häirete raviks
ATE307497T1 (de) Pharmazeutische zusammensetzung
BR0314804A (pt) Forma de dosagem de liberação modificada
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
DK0484112T3 (da) Anvendelse af lithium ved behandlingen eller profylakse af Molluscum contagiosum

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP)

Free format text: TRANSFERIDO POR FUSAO DE: FUJISAWA PHARMACEUTICAL CO., LTD.

B25D Requested change of name of applicant approved

Owner name: ASTELLAS PHARMA INC. (JP)

Free format text: ALTERADO DE: YAMANOUCHI PHARMACEUTICAL CO., LTD.

B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.